Cellectis
CLLS
60 hedge funds and large institutions have $226M invested in Cellectis in 2019 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 16 closing their positions.
16,500% more call options, than puts
Call options by funds: $332K | Put options by funds: $2K
66% more capital invested
Capital invested by funds: $137M → $226M (+$89.7M)
0.18% more ownership
Funds ownership: 30.97% → 31.15% (+0.18%)
6% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 17
6% less funds holding
Funds holding: 64 → 60 (-4)
19% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
+$4.09M |
| 2 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
+$1.93M |
| 3 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$1.36M |
| 4 |
D.E. Shaw & Co
New York
|
+$736K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$352K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.66M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.95M |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$534K |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
-$469K |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$469K |
CLLS Hedge Fund Activity: Q4 2019 in Review
60 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q4 2019, worth a combined $226M — up 66% from $137M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of CLLS and 13 opened new positions — a net loss of 3 holders — while 17 trimmed existing stakes and 16 added.
The largest buyer was Capital International Investors, adding an estimated $4.09M. The largest seller was Fidelity Investments, cutting an estimated $3.66M.
- 60 institutional investors held Cellectis (CLLS) as of Q4 2019, down from 64 in Q3 2019.
- Funds reported $226M of Cellectis stock for Q4 2019, up 66% quarter-over-quarter.
- 13 funds opened new Cellectis positions in Q4 2019 and 16 closed out, a net change of -3 holders.
- The largest Cellectis buyer in Q4 2019 was Capital International Investors, an estimated $4.09M added.
- The largest Cellectis seller in Q4 2019 was Fidelity Investments, an estimated $3.66M sold.
Based on aggregated 13F filings for Q4 2019.